The Leukemia & Lymphoma Society of Canada
Regina Kulikowski is an accomplished professional with extensive experience in leadership and strategic planning across various sectors. Currently serving as Vice President at The Leukemia & Lymphoma Society of Canada since April 2017, Regina empowers constituents to advance the mission of curing blood cancers while improving the quality of life for those affected. Regina previously held the position of President at Regina K, a marketing and research consultancy, where focus was on delivering customer-centric solutions and strategic planning from January 2010 to January 2017. Prior experience includes serving as VP of Strategic Planning at InsightOut/inVentiv, where Regina was instrumental in driving business growth for a start-up division, and as Media Director at JSA, where Regina expanded healthcare communications capabilities through media planning and training. Regina holds a BA Hon. in English and Psychology from the University of Toronto - University of Trinity College, earned between 1982 and 1986.
This person is not in any teams
The Leukemia & Lymphoma Society of Canada
The Leukemia & Lymphoma Society of Canada (LLSC) is a voluntary health agency dedicated to blood cancer. LLSC funds lifesaving blood cancer research across Canada and worldwide, and provides free information and support services. We won’t stop until there is a cure for leukemia, lymphoma, myeloma, myelodysplastic syndromes and myeloproliferative neoplasms and are able to improve the quality of life of people affected by blood cancers and their families by funding life-enhancing research and providing educational resources, services and support. Our strategy to achieve the mission is based on three areas of focus: research, patient support and advocacy. In 2017, we invested almost $7.4 million in the creation of programs and delivery of services to improve the lives of Canadians affected by blood cancers from coast to coast. This investment included a commitment of over $4.1 million in innovative, life-changing research to accelerate new cancer treatments, therapies, and cures; and $3.3 million towards funding patient services, programs and education across Canada. Everything we do is made possible through the generosity of individuals, corporate partners, and foundations. In the last two decades alone, the Leukemia & Lymphoma Society of Canada has raised $207 million for research and services. We receive no government support.